European journal of anaesthesiology
-
Randomized Controlled Trial
Effect of auditory evoked potential-guided anaesthesia on consumption of anaesthetics and early postoperative cognitive dysfunction: a randomised controlled trial.
Post-operative cognitive dysfunction (POCD) after non-cardiac surgery is a well known problem in some categories of patients. This study aims to evaluate the influence of auditory evoked potential (AEP)-guided anaesthesia on the requirement for anaesthetic drugs and their influence on POCD. ⋯ AEP monitoring allows dose reduction of anaesthetic agents, leading to better cardiovascular stability and decreased requirements for intra-operative fluids and vasopressors. Cognitive decline seen following minor ophthalmic surgery, even when anaesthesia is assessed clinically, is short-lived with no long-term sequelae.
-
Randomized Controlled Trial Comparative Study
Validation of a model of graded difficulty in Laerdal SimMan: functional comparisons between Macintosh, Truview EVO2, Glidescope Video Laryngoscope and Airtraq.
A randomised, cross-over study was designed to validate a new model of graded difficulty (based on mandibular space reduction) in the Laerdal 'SimMan' mannnequin and to suggest functional comparisons between Macintosh. Glidescope Video Laryngoscope, Truview EVO2 and Airtraq. ⋯ Our study suggests that Glidescope and, to some extent Truview, are functionally similar to Macintosh and suffer from similar limitations in the difficult setting. On the contrary, Airtraq was functionally unique in providing good laryngeal exposure in the difficult setting and without excessive tongue compression.
-
The end-tidal desflurane concentration required for smooth removal of the laryngeal mask airway (LMA) has not been established. Therefore, we aimed to find the end-tidal desflurane concentration for safe, smooth, and uncomplicated LMA removal. ⋯ The EC95 of end-tidal desflurane for the smooth removal of the LMA is 3.9%. LMA removal in adults receiving desflurane may be possible at approximately 0.7 minimum alveolar concentration.